Publications by authors named "Michael B Strong"

Claim this Profile
I
Insulin therapy and outcomes of revascularization procedures for chronic limb-threatening ischemia in the BEST-CLI trial.
Dana Alameddine, Mohammed Hamouda, Gheorghe Doros, Michael S Conte, Kenneth Rosenfield, Michael B Strong

J Vasc Surg· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomic profile of arterial occlusive disease in the BEST-CLI trial.
Katharine L McGinigle, Christina W Zhou, Nikki L B Freeman, Michael S Conte, Michael B Strong

J Vasc Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI Trial.
Richard J Powell, Matthew T Menard, Kenneth Rosenfield, Michael B Strong, Michael S Conte

J Vasc Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of Race and Ethnicity After Revascularization in the BEST-CLI Trial.
Olamide Alabi, Gheorghe Doros, Mohammed Hamouda, Michael S Conte, Alik Farber, Michael B Strong

Ann Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rates of nonindex limb amputation in the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial.
Tze-Woei Tan, Kirsten D Dansey, Alik Farber, Gheorghe Doros, Matthew T Menard, Michael B Strong

J Vasc Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Outcomes of Lower Extremity Vein Bypass for Chronic Limb-Threatening Ischemia Based on a Post Hoc Comparison of BEST-CLI and PREVENT III Multicenter Prospective Randomized Controlled Trials.
Mohamad A Hussain, Ali A Khan, Matthew T Menard, Michael S Conte, Ageliki G Vouyouka, Michael B Strong

J Vasc Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative endovascular drug technology is associated with fewer major reinterventions after femoropopliteal interventions for chronic limb-threatening ischemia.
Jeffrey J Siracuse, John A Kaufman, Alik Farber, Matthew T Menard, Kenneth Rosenfield, Michael B Strong

J Vasc Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Anatomical Patterns of Arterial Occlusive Disease and Endovascular Outcomes in the BEST-CLI Trial Supports the Use of the Global Limb Anatomic Staging System.
Katharine L McGinigle, Matthew T Menard, Gheorghe Doros, Michael B Strong, Alik Farber

Eur J Vasc Endovasc Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemia.
Zafar Zafari, Mehdi Najafzadeh, Mufaddal Mahesri, HoJin Shin, Philip P Goodney, Michael B Strong

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia.
Sreekanth Vemulapalli, Gheorghe Doros, E Hope Weissler, W Schuyler Jones, Shuang Li, Michael B Strong

JACC Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
Joshua A Beckman, Alain T Drooz, Alik Farber, Allen Hamdan, Thomas Huber, Michael B Strong

Circulation· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia.
Michael B Strong, Alik Farber, David G Armstrong, Nobuyoshi Azuma, Joshua A Beckman

Br J Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial.
Douglas W Jones, Alik Farber, David G Armstrong, Ezana Azene, Audra Duncan, Michael B Strong

J Vasc Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Choice - Bypass After Failed Endovascular Intervention Is Associated with an Increased Risk of Above Ankle Amputation Among Patients with Chronic Limb Threatening Ischaemia in a Randomised Trial Population.
Alik Farber, Matthew T Menard, Michael S Conte, Kenneth Rosenfield, Caitlin W Hicks, Michael B Strong

Eur J Vasc Endovasc Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Hispanic patients undergoing open bypass in BEST-CLI.
Jesus G Ulloa, Olamide Alabi, Katharine McGinigle, John Lane, Gheorghe Doros, Michael B Strong

J Vasc Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence and Consequences of Endovascular Technical Failure in Patients with Chronic Limb-Threatening Ischemia: Results from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb-Threatening Ischemia (BEST-CLI) Trial.
Richard J Powell, Alik Farber, Gheorghe Doros, David Chew, Michael S Conte, Michael B Strong

J Vasc Interv Radiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI.
Khanjan B Shah, Hanaa Aridi, Michael D Dake, Gheorghe Doros, Alik Farber, Michael B Strong

Circ Cardiovasc Interv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.
Mahmoud B Malas, Mohammed Hamouda, Alik Farber, Matthew T Menard, Michael S Conte, Michael B Strong

J Vasc Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Medical Therapy Is Associated With Improved Limb Outcomes in PAD Patients: A BEST-CLI Substudy.
Vikram S Kashyap, Joshua A Beckman, Gheorghe Doros, Matthew T Menard, Kenneth Rosenfield, Michael B Strong

J Am Coll Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial.
Jeffrey J Siracuse, Alik Farber, Matthew T Menard, Kenneth Rosenfield, Michael S Conte, Michael B Strong

J Vasc Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia.
Michael S Conte, Alik Farber, Andrew Barleben, Emiliano Chisci, Gheorghe Doros, Michael B Strong

Circ Cardiovasc Interv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia.
Alik Farber, Matthew T Menard, Michael S Conte, Kenneth Rosenfield, Marc Schermerhorn, Michael B Strong

J Vasc Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.
Katharine L McGinigle, Gheorghe Doros, Olamide Alabi, Benjamin S Brooke, Ageliki Vouyouka, Michael B Strong

J Vasc Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
Matthew T Menard, Alik Farber, Gheorghe Doros, Katherine L McGinigle, Emiliano Chisci, Michael B Strong

J Vasc Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.
Kristina A Giles, Alik Farber, Matthew T Menard, Michael S Conte, Brian W Nolan, Michael B Strong

J Vasc Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis